Author: Hushmandi, Kiavash; Bokaie, Saied; Hashemi, Mehrdad; Moghadam, Ebrahim Rahmani; Raei, Mehdi; Hashemi, Farid; Bagheri, Mahdi; Habtemariam, Solomon; Nabavi, Seyed Mohammad
Title: A review of medications used to control and improve the signs and symptoms of COVID-19 patients Cord-id: 5n87rsus Document date: 2020_9_19
ID: 5n87rsus
Snippet: In December 2019, an unprecedented outbreak of pneumonia associated with a novel coronavirus disease 2019 (COVID-19) emerged in Wuhan City, Hubei province, China. The virus that caused the disease was officially named by the World Health Organization (WHO) as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). According to the high transmission rate of SARS-CoV-2, it became a global pandemic and public health emergency within few months. Since SARS-CoV-2 is genetically 80% homologo
Document: In December 2019, an unprecedented outbreak of pneumonia associated with a novel coronavirus disease 2019 (COVID-19) emerged in Wuhan City, Hubei province, China. The virus that caused the disease was officially named by the World Health Organization (WHO) as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). According to the high transmission rate of SARS-CoV-2, it became a global pandemic and public health emergency within few months. Since SARS-CoV-2 is genetically 80% homologous with the SARS-CoVs family, it is hypothesized that medications developed for the treatment of SARS-CoVs may be useful in the control and management of SARS-CoV-2. In this regard, some medication being tested in clinical trials and in vitro studies include anti-viral RNA polymerase inhibitors, HIV-protease inhibitors, anti-inflammatory agents, angiotensin converting enzyme type 2 (ACE 2) blockers, and some other novel medications. In this communication, we reviewed the general characteristics of medications, medical usage, mechanism of action, as well as SARS-CoV-2 related trials.
Search related documents:
Co phrase search for related documents- active form and adenosine analogue: 1, 2, 3
- active form and administration food: 1, 2, 3, 4
- active form and liver intestine: 1
- active form and loading dose: 1
- active form prodrug and administration food: 1
- active form prodrug and liver intestine: 1
- acute ards respiratory distress syndrome and administration food: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and adolescent adult: 1
- acute ards respiratory distress syndrome and loading dose: 1
- adenosine analogue and administration food: 1
- administration food and adolescent adult: 1, 2
- administration food and loading dose: 1
Co phrase search for related documents, hyperlinks ordered by date